Literature DB >> 18187969

[Oxidative stress and antioxidant factors in pathophysiology of allergic rhinitis].

Ercan Akbay1, Hamdi Arbağ, Yavuz Uyar, Kayhan Oztürk.   

Abstract

OBJECTIVES: We evaluated the role of oxidative stress and antioxidants in the etiopathogenesis of allergic rhinitis. PATIENTS AND METHODS: The study included 40 patients (13 males, 27 females; mean age 30+/-14 years; range 4 to 63 years) with allergic rhinitis. The mean symptom duration was 5.2+/-4.9 years. Blood and serum samples were analyzed spectrophotometrically. Myeloperoxidase (MPO) activity and vitamins A and E were measured as enzymatic and non-enzymatic antioxidants, respectively. Oxidative stress was determined by the malondialdehyde (MDA) level. Total antioxidant capacity (TAC) was measured as the total antioxidant activity against oxidative stress products. The results were compared with those of a control group consisting of 40 healthy individuals.
RESULTS: Compared to the control group, the mean MDA level was significantly higher, and the mean MPO, vitamin A and E levels, and TAC were significantly lower in the patient group (p<0.05).
CONCLUSION: Our results suggest that imbalances between oxidative stress and antioxidant defence mechanisms may play a role in the etiopathogenesis of allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18187969

Source DB:  PubMed          Journal:  Kulak Burun Bogaz Ihtis Derg        ISSN: 1300-7475


  2 in total

1.  Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice.

Authors:  Xiao-Lan Li; Ai-Guo Zhou; Li Zhang; Wei-Jun Chen
Journal:  Int J Mol Sci       Date:  2011-01-26       Impact factor: 5.923

2.  Efficacy of Supportive Therapy of Allergic Rhinitis by Stinging Nettle (Urtica dioica) root extract: a Randomized, Double-Blind, Placebo- Controlled, Clinical Trial.

Authors:  Mehdi Bakhshaee; Amir Hooshang Mohammad Pour; Majid Esmaeili; Farahzad Jabbari Azad; Ghazal Alipour Talesh; Maryam Salehi; Morteza Noorollahian Mohajer
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.